(Q34182611)

English

Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

author name string

Francisco J de Abajo

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

345-367

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Psychiatric disorders in older primary care patients

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Epidemiology of late-life mental disorders

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Clinical practice. Late-life depression

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depression treatment in a sample of 1,801 depressed older adults in primary care

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The expanded biology of serotonin

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Platelet activation in depression and effects of sertraline treatment: An open-label study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Coated-platelets: an emerging component of the procoagulant response

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Coated-platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Serotonin transporter polymorphism and bleeding time during SSRI therapy

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Association between SSRIs and upper gastrointestinal bleeding. Coprescription of antiulcer drugs with SSRIs is fairly common

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressant drug prescription and risk of abnormal bleeding: a case-control study.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Use of Serotonergic Drugs and the Risk of Bleeding

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The coadministration of paroxetine and low-dose aspirin synergistically enhances gastric ulcerogenic risk in rats

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Use of serotonergic antidepressants and bleeding risk in orthopedic patients

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressants, warfarin, and the risk of hemorrhage

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Risk of clinically relevant bleeding in warfarin-treated patients--influence of SSRI treatment

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depressive Symptoms and Risk of Stroke: The Framingham Study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depression, alterations in platelet function, and ischemic heart disease

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The impact of depression in heart disease

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Risk of ischemic stroke associated with antidepressant drug use in elderly persons

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Epidemiology of comorbid coronary artery disease and depression

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depression and cardiovascular disease: healing the broken-hearted

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Poststroke depression: prevalence, diagnosis, treatment, and disease progression

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Prospective study of depressive symptoms and risk of stroke among japanese

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Does stroke cause depression?

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Does treating depression improve survival after acute coronary syndrome? Invited commentary on... Effects of antidepressant treatment following myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effects of antidepressant treatment following myocardial infarction.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Mirtazapine: a review of its use in major depression and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Depression and Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.2165%2F11589340-000000000-00000

21 January 2018

Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine-associated bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine and bleeding in obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venlafaxine and ecchymosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major depressive disorder predicts cardiac events in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine decreases platelet serotonin storage and platelet function in human beings

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics and the serotonin transporter in late-life depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonergic mechanisms enhance platelet-mediated thrombogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in antidepressant prescriptions among the elderly in Alberta during 1997 to 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding attributed to the intake of paroxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of genetic variation in the serotonin transporter promoter region: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressants and risk of upper gastrointestinal bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged bleeding time in a patient treated with sertraline

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression and cardiovascular comorbidity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression and coronary heart disease: more pieces of the puzzle

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in antidepressant utilization from 2001 to 2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of antidepressants on hemostasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine and hemostatic function: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal platelet aggregation associated with fluoxetine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common genetic factors for depression and cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine and the bleeding time

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding gums: duloxetine may be the cause

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21542658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11589340-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34182611&oldid=2196359042"